WayBetter
Wilmington, Delaware, 19807, United States
NCT Number: NCT05075213
This study is a randomized controlled trial (RCT) of QuitBet, a digital contingency management program for smoking cessation. QuitBet combines social gaming elements with participant-funded financial incentives in the form of a deposit contract. QuitBet "players" deposit (called the "bet") a specified amount of their own money into the game's "pot." All "winners" who achieve the game's goal split the pot equally, such that their bet is fully refunded plus they receive extra money from the forfeited bets of players who did not meet the goal. Participants (N = 550) will be randomly assigned to QuitBet or QuitBet-NS (deposit contract only, no social elements). All participants will be offered a second game after their first game (up to 8 weeks total game duration) and will be asked to complete a survey after each game and at 1 and 4 months after the end of the second game (3 and 6 months after the start of their first game). The study will compare QuitBet vs. QuitBet-NS on smoking behavior outcomes and examine potential mediators of outcomes such as motivation, engagement, and satisfaction.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Not applicable
Wilmington, Delaware, 19807, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Participants will deposit $30 of their own money to play QuitBet. Participants will submit a CO test once per day between the hours of noon and 11:59pm. Participants whose CO test is 6ppm or lower (indicating no smoking) on at least 24 of 26 days between day 3-28 of the game will be declared winners and split the pot of deposited money. Participants who submit at least 21 CO tests, regardless of the result, will be entered into a raffle to win a prize worth $75.
Participants will have access to a discussion board on which participants can post and respond to messages to each other. Also, a game host will post educational information about smoking cessation and serve as a discussion moderator.
Participants will have access to a list of smoking cessation resources
Time frame: 6 months after the start date of their first QuitBet game
At 6 month follow-up, participant reported no smoking during the past 7 days (survey question: "Have you smoked a cigarette, even just a puff, during the past 7 days?" with answer choices of "yes" or "no" - participant responded "no").
Time frame: 4 weeks after the start date of their first QuitBet game (end of game), when they were given the option to join a second game
Number of participants who chose to play a second QuitBet game
Time frame: 6 months after the start of their first QuitBet game
At 6 month follow up, the number of cigarettes the participant reported smoking during the previous 7 days (survey respondents only).
In the 6 month follow-up survey, participants were first asked "Have you smoked a cigarette, even just a puff, during the past 7 days?" (yes/no answer choice). Participants who answered "no" were counted as smoking 0 cigarettes in this analysis. Participants who answered "yes" were then asked to report how many cigarettes they smoked on each day during the past week (day 1 being this day last week, day 2, day 3, day 4, day 5, day 6, day 7 being yesterday). The average of the 7 days was used in this analysis.
Time frame: 6 month period beginning with the start of their first QuitBet game
Number of participants who reported use of any smoking cessation medication (including any form of nicotine replacement therapy, buproprion, or varencline) at any time during their participation in the study, from the start of their first QuitBet game until the last follow-up 6 months later
WayBetter, Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05130788
Behavior, Health Behavior
New York, United States
View Trial DetailsNCT06663020
Behavior, Bronchial Neoplasms
Samsun, Turkey (Türkiye)
View Trial DetailsNCT04881630
Behavior, Health Behavior
Oklahoma City, Oklahoma, United States
View Trial DetailsNCT04620915
Behavior, Cancer
Eugene, Oregon, United States
View Trial Details